Next Article in Journal
Effect of Syringopicroside Extracted from Syringa oblata Lindl on the Biofilm Formation of Streptococcus suis
Next Article in Special Issue
Methylation of Cyanidin-3-O-Glucoside with Dimethyl Carbonate
Previous Article in Journal
Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment
Previous Article in Special Issue
Molecular and Cellular Effects of Chemical Chaperone—TUDCA on ER-Stressed NHAC-kn Human Articular Chondrocytes Cultured in Normoxic and Hypoxic Conditions
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 26
Issue 5
10.3390/molecules26051296
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Assignment of Absolute Configuration of Bromoallenes by Vacuum-Ultraviolet Circular Dichroism (VUVCD)

by
Taiki Umezawa
1,*,
Nakaba Mizutani
1,
Koichi Matsuo
2,
Yuugo Tokunaga
3,
Fuyuhiko Matsuda
1 and
Tatsuo Nehira
3,4,*
1
Division of Environmental Materials Science, Graduate School of Environmental Science, Hokkaido University, N10W5, Kita-ku, Sapporo 060-0810, Japan
2
Hiroshima Synchrotron Radiation Center (HiSOR), Hiroshima University, 2-313 Kagamiyama, Higashi-Hiroshima 739-0046, Japan
3
Faculty of Integrated Arts and Sciences, Hiroshima University, 1-7-1 Kagamiyama, Higashi-Hiroshima 739-8521, Japan
4
Graduate School of Integrated Sciences for Life, Hiroshima University, 1-7-1 Kagamiyama, Higashi-Hiroshima 739-8521, Japan
*
Authors to whom correspondence should be addressed.
Molecules 2021, 26(5), 1296; https://doi.org/10.3390/molecules26051296
Submission received: 6 February 2021 / Revised: 22 February 2021 / Accepted: 22 February 2021 / Published: 27 February 2021
(This article belongs to the Special Issue Recent Advances on Natural Product Research)
Browse Figures
Review Reports Versions Notes

Abstract

:
A new application of vacuum-ultraviolet circular dichroism (VUVCD), which enables the measurement of CD spectra in the vacuum-ultraviolet region (140–200 nm), for the assignment of the absolute configurations of bromoallenes is described. Bromoallene moieties are found in natural products obtained from many marine organisms. To date, the absolute configuration of bromoallenes has been assigned almost exclusively with Lowe’s rule, which is based on specific rotation. However, exceptions to Lowe’s rule have been reported arising from the presence of other substituents with large specific rotations. For the unambiguous assignment of the absolute configuration of the bromoallene moiety with its characteristic absorption wavelength at 180–190 nm due to the π–π* transition, VUVCD was applied to four pairs of bromoallene diastereomers prepared by modifying the synthetic scheme of omaezallene. The VUVCD spectra clearly showed positive or negative Cotton effects around 180–190 nm according to the configuration of the bromoallene employed, revealing the potential of VUVCD for determining absolute stereochemistry.

1. Introduction

Natural products with bromoallene moieties are found in many marine organisms and possess various biological activities [1]. 1,3-Disubstituted bromoallene has an axial chirality that induces polarization. In general, the specific rotation by the bromoallene functionality shows a large absolute value whose sign corresponds to its absolute configuration. This is based on Lowe’s rule, an empirical rule in which a minus value is assigned to a bromoallene with R configuration and a plus value to the S configuration [2]. Lowe’s rule has been widely employed for the assignment of absolute configurations of allene moieties found in newly isolated natural products [3,4,5,6,7,8,9,10,11,12]. However, exceptions to Lowe’s rule have been reported. Specific rotations of allene moieties can be disrupted by the influence of other substituents [13,14]. We encountered an exception to Lowe’s rule in the total synthesis of omaezallene (1) (Figure 1) [13]. Although 1 and Z-omaezallene (2) followed the rule, their 9-epimers, 9-epi-1 and 9-epi-2, had opposite signs of specific rotation to those of 1 and 2. This is presumably attributable to interference from the substituent at the 9 position. Thus, for the unambiguous assignment of the absolute configuration of the bromoallene moiety, development of a convenient and reliable methodology was required.
We envisioned vacuum-ultraviolet circular dichroism (VUVCD), which measures CD spectra in the vacuum-ultraviolet region (minimum wavelength is 140 nm) [15,16], for unambiguous determination of absolute configuration. The bromoallene moiety typically has a characteristic absorption around 180–190 nm corresponding to the π–π* transition [17]. We anticipated that expanding the utility of VUVCD would be helpful since VUVCD has provided extra insights into the absolute configurations and conformations of biomolecules [18], such as sugars [19], amino acids [20], and proteins [21,22]. Herein, we describe syntheses of a series of bromoallene diastereomers by modifying the synthetic scheme of omaezallene and their VUVCD spectral analyses.

2. Results and Discussion

In order to prepare object-oriented diastereomeric pairs that feature both configurations at the bromoallene moiety, modifications to our previous synthesis were necessary. Construction of propargyl alcohol 5, a stereospecific precursor for the bromoallene, was previously carried out in a stereoselective manner with acetylide and hemiacetal 4 obtained from d-glucose through aldehyde 3 (Scheme 1). We believe this high stereoselectivity was due to the hydroxy group in the α-hydroxyaldehyde 4′, which was in equilibrium with hemiacetal 4 [13]. Thus, we planned the direct addition of the acetylide to aldehyde 3, anticipating that the absence of the hydroxy group in the substrate would provide a mixture of diastereomeric alcohols 6 and 7. Further manipulations of the acetal moiety were expected to give diastereomeric alcohols 8 as appropriate intermediates for both enantiomers of omaezallene.
As shown in Scheme 2, the synthesis began with aldehyde 3 [23], which was treated with acetylide to give diastereomeric propargyl alcohols 6 and 7 as an inseparable mixture (dr = 1.6:1). After several attempts to separate the diastereomers, esterification of the mixture with a commercially available (R)-O-methylmandelic acid allowed separation of the two isomers by silica gel column chromatography. The absolute configurations of the propargyl alcohols were revealed to be R for the less polar ester 9 and S for the more polar ester 10 by the modified Mosher method [24] (see Figure S1 in the Supplementary Material). Thus, both isomers of the bromoallene were now accessible. Ester 10 was converted to bromoallene (1S)-12 in 3 steps: hydrolysis of the ester, sulfonate formation [25,26], and stereospecific installation of the bromoallene moiety to sulfonate 11. A two-step sequence through deprotection of the acetal with TsOH, followed by Wittig reaction [27], afforded unsaturated ester (1S)-13. After reduction of the ester to an allylic alcohol, tetrahydrofuran (1S)-14 was successfully obtained by bromoetherification with NBS in a highly diastereoselective manner [28,29,30,31] without loss of the bromoallene functionality. The treatment of (1S)-14 with TBSOTf and 2,6-lutidine provided silyl ether (1S)-8 after the less hindered TBS ether was selectively removed under mild acidic conditions [32]. 1H and 13C NMR spectra of (1S)-8 were identical with those of the previous intermediate of omaezallene [13]. Furthermore, the specific rotation of this newly prepared (1S)-8 was +61.3 (c 1.10, CHCl3), indicating that the enantiomer of the previous intermediate [−68.0 (c 0.75, CHCl3)] was successfully prepared from the same starting material [13]. Diastereomer 9 was converted to alcohol (1R)-8 by the same scheme as for (1S)-8.
With several pairs of bromoallene diastereomers in hand, (1S)-/(1R)-12, (1S)-/(1R)-13, (1S)-/(1R)-14, and (1S)-/(1R)-15, we turned our attention to collecting VUVCD spectra. The results are summarized in Figure 2. These compounds followed Lowe’s rule for bromoallene structures, exhibiting positive and negative values of specific rotations for the S and R isomers, respectively. All compounds had the characteristic absorption around 190 nm corresponding to the π–π* transition in UV spectroscopy. Positive Cotton effects were observed at the wavelength region of interest for all S bromoallenes and negative ones for all R bromoallenes, despite the presence of various functional groups such as hydroxy groups, acetals, esters, or silyl ethers. The relationship between the signs of the CD spectra of all of these compounds and their absolute configurations is consistent well with that obtained for other chiral allenes [33], implying that this π–π* transition of interest may be applicable to other types of allene derivatives. While these transitions were previously either non-observable or visualized only by gas-phase measurements, our results demonstrate the potential of VUVCD for the robust assignment of absolute configurations of bromoallenes.
The obtained VUVCD spectra of all the bromoallenes were compared to the theoretical CD spectra predicted by quantum mechanics calculations [34]. Starting from a conformational search, the resultant stable conformers were optimized by density functional theory calculations at the B3LYP/6-31G(d) level of theory, followed by conformational analysis by Boltzmann’s law to estimate dominant conformers. Theoretical CD spectra were produced by performing time-dependent density functional theory calculations at the double-zeta level using several functionals that had been previously used in several CD calculation studies. Although spectra from different functionals did not always agree well with the experimental ones as shown in Figure 3, comparison between several functionals provided us with an encouraging sense of accomplishment: the conclusion was always the same no matter what functional was used. In the current study, the functional B3LYP tended to give better agreement than BHandHLYP, or CAM-B3LYP. Changing basis sets did not significantly affect the shape of the theoretical spectra.
This approach of VUVCD measurement and interpretation has yielded the following three important arguments for this method. First, bromoallenes were expected to show intense Cotton effects at the wavelength corresponding to distinct absorption peaks at 180–190 nm, which were clearly observable by VUVCD and agreed well with the previous report [33]. This is also encouraging since a couple of reports demonstrated that VUVCD spectra were applicable to solutions of not only water but also organic solvents [35,36]. Second, the signs of the Cotton effect in the bromoallenes were in accordance with the absolute configurations in both experimental VUVCD and theoretical CD spectra throughout the models of this study. This configurational discussion showed a complete match with the reported work of our omaezallene synthesis [13]. Third, both the absorption peak and the CD extreme of the bromoallenes were easy to assign because they were isolated from peaks arising from other functional groups. Since this theoretical prediction of CD spectra is nonempirical, requiring no reference sample, the method is expected to be helpful for any sample of interest as long as the experiment is feasible.
In summary, concise preparations of bromoallene diastereomers and their VUVCD analyses have been described. Addition of an acetylide Grignard reagent to an aldehyde gave a mixture of diastereomers, which were separated by esterification with an optically active carboxylic acid. Further transformations enabled the synthesis of diastereomeric pairs of various bromoallene-containing omaezallene intermediates. The current VUVCD results demonstrate its potential for the unambiguous assignment of the absolute configuration of bromoallenes instead of Lowe’s rule. It is also advantageous that VUVCD spectra of bromoallenes can be interpreted theoretically. Further research on various bromoallenes, including compounds that do not follow Lowe’s rule, are underway.

3. Materials and Methods

3.1. General Methods

Tetrahydrofuran, diethyl ether, acetone, acetonitrile, and 1,2-dichloroethane (dehydrated grade) were purchased from Kanto Chemical Co., (Tokyo, Japan). Inc. Dichloromethane (CH2Cl2), and triethylamine (Et3N) were distilled from CaH2. All commercially obtained reagents were used as received. Analytical and preparative TLC were carried out using pre-coated silica gel plates (Macherey-Nagel DC-Fertigplatten SIL G-25 UV254), purchased from Merck (Darmstadt, Germany). Merck Kieselgel 60 Art 7734 silica gel was used for column chromatography. IR spectra were recorded on a JASCO FTIR-4100 Type A spectrometer, purchased from JASCO (Tokyo, Japan), using a NaCl cell or a KBr board. 1H- and 13C-NMR spectra were recorded using a JNM-EX 400 (400 MHz and 100 MHz) spectrometer, purchased from JEOL (Tokyo, Japan). Chemical shifts are reported in ppm relative to CHCl3 (δ = 7.26) in CDCl3 for 1H NMR, and CDCl3 (δ = 77.0) for 13C NMR. Splitting patterns are designated as s, d, t, q, and m, indicating singlet, doublet, triplet, quartet, and multiplet, respectively. The VUVCD spectra were measured in the wavelength region from 200 to 175 nm at 25 °C using a VUVCD spectrophotometer at the Hiroshima Synchrotron Radiation Center (HiSOR), Hiroshima University [18]. This spectrophotometer uses a synchrotron radiation light source to observe the CD spectrum in the high energy region. The details of the optical devices of the spectrophotometer are available elsewhere [15,16]. The VUVCD measurements were carried out using an assembled-type optical cell with CaF2 windows [18]. The path length in the cell was adjusted using a Teflon spacer to 50 μm. The sample solutions were freshly prepared by dissolving in acetonitrile at an appropriate concentration, which was determined based on the reported molar absorption coefficient [33]. All of the spectra were recorded using a 1.0-mm slit, 4-s time constant, 20-nm/min scan speed, and four accumulations. UV absorbance was derived from the high-tension voltage for the CD measurement. Conformational searches were performed with CONFLEX 8 (Version 8.A.0901 by CONFLEX, Tokyo) [37] using a commercially available PC (Operating System: Windows 10 Pro for Workstations, CPU: Intel Xeon E5-1650 v4 processor 3.60 GHz, RAM 32 GB) and density functional theory (DFT) calculations were conducted with Gaussian 09 (Revision E.01 by Gaussian, Wallingford, CT) [38] with a PC (Operating System: CentOS 7 a Linux, CPU: Intel Xeon E5-1660 v4 processor 3.20 GHz, RAM 32 GB).

3.2. Syntheses

3.2.1. Propargyl Alcohols 6 and 7

To a solution of aldehyde 3 (3.10 g, 18.0 mmol) in THF (50 mL) was added 0.5 M ethynylmagnesium chloride (72.0 mL, 36.0 mmol) at 0 °C under Ar atmosphere. The mixture was stirred for 2 h at 0 °C, quenched with diluted HCl, extracted with AcOEt, washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography (AcOEt:hexane = 15:85 then 30:70) to give mixture of propargyl alcohols 6 and 7 (3.07 g, 15.5 mmol, 86%) as an inseparable mixture:
Spectroscopic data of 6 and 7 after separation by next conversions are follows:
6 [α]D24 −14.9 (c 1.07, CHCl3); IR (neat) 3448, 3273, 2989, 2937, 2904, 2114, 1456, 1435, 1375, 1258, 1219, 1164, 1056, 1024, 850, 665, 540, 524 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.33 (3H, s), 1.53 (3H, s), 1.84 (1H, ddd, J = 14.4, 9.5, 4.9 Hz), 2.19 (1H, dd, J = 13.7, 4.4 Hz), 2.28 (1H, d, J = 6.3 Hz), 2.50 (1H, d, J = 2.0 Hz), 4.31–4.39 (2H, m), 4.77 (1H, t, J = 4.1 Hz), 5.84 (1H, dd, J = 2.0 Hz); 13C NMR (CDCl3, 100 MHz) δ 26.2, 26.8, 34.7, 64.0, 74.2, 80.5, 80.6, 81.2, 105.9, 111.7; HRMS (ESI) m/z: [M + Na]+; calculated for C10H14O4Na 221.0788; Found 221.0787.
7 [α]D23 −15.6 (c 0.96, CHCl3); IR (neat) 3473, 3254, 2994, 2984, 2965, 2948, 2904, 2120, 1435, 1372, 1321, 1255, 1212, 1167, 1123, 1053, 1018, 938, 850, 720, 673 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.33 (3H, s), 1.53 (3H, s), 2.03 (1H, ddd, J = 14.4, 10.2, 4.4 Hz), 2.16 (1H, dd, J = 13.7, 4.9 Hz), 2.24 (1H, d, J = 4.9 Hz), 2.46 (1H, d, J = 2.9 Hz), 4.42 (1H, ddd, J = 10.4, 4.9, 3.4 Hz), 4.63 (1H, quin, J = 2.6 Hz), 4.78 (1H, t, J = 4.4 Hz), 5.85 (1H, dd, J = 3.9 Hz); 13C NMR (CDCl3, 100 MHz) δ 26.2, 26.8, 32.5, 62.3, 74.4, 80.2, 80.5, 105.8, 111.7; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C10H14O4Na 221.0788; Found 221.0784.

3.2.2. Ester 9 and 10

To a solution of 6 and 7 (mixture, 713 mg, 3.59 mmol) in CH2Cl2 (20 mL) were added (R)-O-methylmandelic acid (628 mg, 3.77 mmol), DMAP (43.9 mg, 0.359 mmol) and EDCI (897 mg, 4.67 mmol) at room temperature under Ar atmosphere. The mixture was stirred at room temperature for 1.5 h, quenched with saturated NaHCO3, extracted with AcOEt, washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography (AcOEt:hexane = 7:93) to give ester 10 (671 mg, 1.94 mmol, 54%) as a colorless oil and ester 9 (419 mg, 1.21 mmol, 34%) as a colorless oil:
9 [α]D23 −74.7 (c 0.87, CHCl3); IR (neat) 3269, 2989, 2938, 2899, 2830, 2127, 1758, 1452, 1370, 1317, 1213, 1166, 1116, 1076, 1025, 848, 743, 700 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.24 (3H, s), 1.41 (3H, s), 1.66 (1H, ddd, J = 13.7, 10.0, 4.9 Hz), 2.00 (1H, dd, J = 13.7, 4.9 Hz), 2.48 (1H, d, J = 2.4 Hz), 3.39 (3H, s), 4.29 (1H, dt, J = 9.3, 4.1 Hz), 4.40 (1H, t, J = 4.2 Hz), 4.81 (1H, s), 5.08 (1H, d, J = 3.4 Hz), 5.74 (1H, t, J = 2.7 Hz), 7.33–7.40 (3H, m), 7.42–7.45 (2H, m); 13C NMR (CDCl3, 100 MHz) δ 25.9, 26.5, 32.3, 57.0, 62.9, 75.0, 78.4, 79.6, 81.7, 105.3, 111.3, 127.1, 128.3, 128.4, 135.8, 168.5; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C19H22O6Na 369.1309; Found 369.1314.
10 [α]D23 −24.1 (c 1.68, CHCl3); IR (neat) 3266, 3066, 3034, 2989, 2938, 2904, 2830, 2124, 1758, 1494, 1452, 1373, 1320, 1238, 1213, 1166, 1105, 1076, 1054, 1025, 957, 883, 848, 737, 698 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.25 (3H, s), 1.52 (3H, s), 1.76 (1H, ddd, J = 13.9, 10.2, 4.9 Hz), 2.20 (1H, dd, J = 13.7, 4.9 Hz), 2.35 (1H, d, J = 2.0 Hz), 3.46 (3H, s), 4.42 (1H, ddd, J = 10.6, 6.6, 4.9 Hz), 4.72 (1H, t, J = 4.2 Hz), 4.84 (1H, s), 5.46 (1H, dd, J = 6.6, 2.0 Hz), 5.82 (1H, d, J = 3.9 Hz), 7.33–7.40 (3H, m), 7.43–7.46 (2H, m); 13C NMR (CDCl3, 100 MHz) δ 26.4, 27.0, 35.4, 57.5, 65.9, 75.8, 78.0, 80.2, 82.3, 106.2, 111.9, 127.6, 128.8, 128.9, 135.7, 169.5; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C19H22O6Na 369.1309; Found 369.1314.

3.2.3. Sulfonate 11

To a solution of 10 (505 mg, 1.46 mmol) in THF (5.0 mL) was added 1.0 M NaOH solution (5.0 mL) at room temperature. The mixture was stirred for 1 h, extracted with Et2O, washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. Crude propargyl alcohol was directly employed in the next reaction.
To a solution of the crude propargyl alcohol in CH2Cl2 (5.0 mL) were added DMAP (366 mg, 3.00 mmol) and TrisCl (848 mg, 2.80 mmol) at room temperature under Ar atmosphere. The mixture was stirred for 12 h and concentrated in vacuo. The residue was purified by silica gel column chromatography (AcOEt:hexane = 2:98 then 8:92) to give sulfonate 11 (612 mg, 1.32 mmol, 91%) as a colorless oil: [α]D23 +5.5 (c 1.19, CHCl3); IR (neat) 3280, 2960, 2870, 2127, 1600, 1563, 1462, 1428, 1380, 1351, 1216, 1179, 1105, 1028, 960, 846, 808, 666 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.24 (3H, s), 1.26 (6H, d, J = 2.4 Hz), 1.27 (12H, d, J = 2.4 Hz), 1.48 (3H, s), 1.96 (1H, ddd, J = 14.3, 9.5, 4.9 Hz), 2.22 (1H, dd, J = 13.7, 4.9 Hz), 2.34 (1H, d, J = 2.4 Hz), 2.90 (1H, sep, J = 7.0 Hz), 4.12 (2H, sep, J = 6.7 Hz), 4.45 (1H, quin, J =5.0 Hz), 4.74 (1H, t, J = 4.1 Hz), 5.24 (1H, dd, J = 5.1, 2.4 Hz), 5.80 (1H, d, J = 3.9 Hz), 7.16 (2H, s); 13C NMR (CDCl3, 100 MHz) δ 23.5, 24.5, 24.6, 24.7, 26.2, 26.9, 29.6, 31.5, 34.2, 69.8, 76.2, 76.6, 77.0, 77.2, 77.3, 77.4, 77.9, 78.7, 80.1, 105.9, 111.9, 123.6, 130.2, 150.7, 153.9; HRMS (ESI-orbitrap) m/z: [M + Na]+; Calcd for C25H36O6NaS 487.2136; Found 487.2134.

3.2.4. Bromoallene (1S)-12

To a solution of 11 (482 mg, 1.04 mmol) in THF (6.0 mL) were added LiBr (903 mg, 10.4 mmol) and CuBr (1.49 g, 10.4 mmol) at room temperature under Ar atmosphere. The mixture was stirred at 60 °C for 2 h, quenched with saturated NaHCO3, filtered through celite pad, extracted with AcOEt, washed with brine, dried over Na2SO4, filtered through short silica gel pad, and concentrated in vacuo. The crude product was purified by silica gel column chromatography (AcOEt:hexane = 5:95) to give bromoallene (1S)-12 (154 mg, 0.590 mmol, 57%) as a colorless oil: [α]D23 +105.7 (c 0.38, CHCl3); IR (neat) 3735, 3650, 2931, 1375, 1015, 850, 660 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.33 (3H, s), 1.52 (3H, s), 1.71 (1H, ddd, J = 13.4, 10.7, 4.4 Hz), 2.27 (1H, dd, J = 13.7, 4.4 Hz), 4.75–4.82 (3H, m), 5.44 (1H, t, J = 6.1 Hz), 5.85 (1H, d, J = 3.9 Hz), 6.10 (1H, dd, J = 5.4, 1.5 Hz); 13C NMR (CDCl3, 100 MHz) δ 25.8, 26.4, 38.8, 73.6, 74.2, 80.0, 99.2, 105.2, 111.1, 202.0; HRMS (ESI-orbitrap) m/z: [M + H]+; calculated for C10H14O379Br 261.0121; Found 261.0123.

3.2.5. Unsaturated Ester (1S)-13

To a solution of (1S)-12 (334 mg, 1.28 mmol) in CH3CN-H2O (11 mL, 10/1) was added TsOH·H2O (33.9 mg) at room temperature under Ar atmosphere. The mixture was stirred at 60 °C for 6 h, quenched with saturated NaHCO3, extracted with AcOEt, washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. Crude hemiacetal was directly employed in the next reaction.
To a solution of the crude hemiacetal in CH2Cl2 (10 mL) was added the nBu3P=CHCO2Et (1.00 M in toluene, 2.67 mL, 2.67 mmol) at room temperature under Ar atmosphere. The mixture was stirred for 1 h and concentrated in vacuo. The crude product was purified by silica gel column chromatography (AcOEt:hexane = 20:80) to give unsaturated ester (1S)-13 (80.4 mg, 0.277 mmol, 31% over 2 steps) as a colorless oil: [α]D23 +31.8 (c 0.68, CHCl3); IR (neat) 3854, 3732, 2979, 1698, 1540, 1308, 1187, 1040 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.31 (3H, t, J = 7.1 Hz), 1.76–1.92 (2H, m), 4.20 (2H, q, J = 7.2 Hz), 4.58–4.63 (2H, m), 5.47 (1H, t, J = 5.9 Hz), 6.10 (1H, dd, J = 15.6, 1.5 Hz), 6.14 (1H, dd, J = 5.9, 2.0 Hz), 6.92 (1H, dd, J = 15.6, 4.9 Hz); 13C NMR (CDCl3, 100 MHz) δ 14.5, 42.4, 60.9, 69.3, 71.0, 75.3, 103.8, 120.9, 148.9, 166.7, 200.9; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C11H15O479BrNa 313.0046; Found 313.0045.

3.2.6. Bromoether (1S)-14

To a solution of (1S)-13 (58.9 mg, 0.200 mmol) in CH2Cl2 (1.0 mL) was added DIBAL (1.00 M in toluene, 1.00 mL, 1.00 mmol) at 0 °C under Ar atmosphere. The mixture was stirred for 30 min, quenched with 1.00 M HCl, stirred for 30 min, extracted with AcOEt, washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo to give crude alcohol, which was directly employed in the next reaction.
To a solution of the crude alcohol in CH3CN (1.0 mL) was added NBS (35.6 mg, 0.200 mmol) at 0 °C under Ar atmosphere. The mixture was stirred for 30 min, quenched with 20% Na2S2O3 aqueous solution, extracted with AcOEt, washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography (AcOEt:hexane = 30:70) to give bromoether (1S)-14 (39.2 mg, 0.120 mmol, 60% over 2 steps) as a colorless oil: [α]D23 +83.5 (c 0.52, CHCl3); IR (neat) 3851, 3735, 3649, 2931, 1698, 1507, 1034, 670 cm–1; 1H NMR (400 MHz, CDCl3) δ 2.03 (1H, ddd, J = 13.8, 9.3, 4.4 Hz), 2.27 (1H, dd, J = 13.4, 5.9 Hz), 3.97 (1H, dd, J = 12.2, 3.9 Hz), 4.02 (1H, dd, J = 12.2, 4.4 Hz), 4.17–4.22 (2H, m), 4.58–4.64 (1H, m), 4.90–4.97 (1H, m), 5.44 (1H, t, J = 5.9 Hz), 6.10 (1H, dd, J = 5.9, 1.5 Hz); 13C NMR (CDCl3, 100 MHz) δ 40.5, 51.3, 65.7, 73.1, 74.1, 76.2, 84.1, 101.1, 201.7; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C9H12O379Br2Na 348.9045; Found 348.9053.

3.2.7. TBS Ether (1S)-15

To a solution of (1S)-14 (61.5 mg, 0.190 mmol) in CH2Cl2 (1.0 mL) were added 2,6-lutidine (110 μL, 0.950 mmol) and TBSOTf (131 μL, 0.570 mmol) at 0 °C under an Ar atmosphere. The mixture was stirred at room temperature for 2 h, quenched with saturated NaHCO3, extracted with AcOEt, washed with 1.00 M HCl and brine, dried over Na2SO4, filtered, and concentrated in vacuo. Crude TBS ether (1S)-15 was sufficiently pure without column chromatography: [α]D23 +49.6 (c 0.81, CHCl3); IR (neat) 3851, 3735, 2928, 1700, 1540, 1254, 1046, 836, 668 cm–1; 1H NMR (400 MHz, CDCl3) δ 0.08 (3H, s), 0.11 (3H, s), 0.12 (3H, s), 0.16 (3H, s), 0.91 (18H, s), 1.90 (1H, ddd, J = 13.2, 9.8, 3.4 Hz), 2.12 (1H, dd, J = 13.2, 5.9 Hz), 3.95–4.15 (4H, m), 4.50 (1H, s), 4.78–4.87 (1H, m), 5.42 (1H, t, J = 6.1 Hz), 6.06 (1H, dd, J = 5.6, 2.0 Hz); 13C NMR (CDCl3, 100 MHz) δ −5.3, −4.8, −4.3, −0.08, 18.0, 18.4, 25.8, 25.9, 41.7, 52.5, 65.1, 73.4, 73.7, 73.8, 75.4, 75.7, 77.2, 82.9, 83.0, 102.0, 201.4; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C21H40O379Br2NaSi2 577.0775; Found 577.0778.

3.2.8. Alcohol (1S)-8

To a solution of the crude(1S)-15 in CH2Cl2-MeOH (0.2 mL, 2:1) was added CSA (13.2 mg, 0.0570 mmol) at room temperature under Ar atmosphere. The mixture was stirred for 90 min, quenched with Et3N (7.9 μL, 0.0570 mmol), and concentrated in vacuo. The crude product was purified by silica gel column chromatography (AcOEt:hexane = 30:70) to give alcohol (1S)-8 (22.5 mg, 0.0513 mmol, 27% over 2 steps) as a colorless oil: [α]D23 +61.3 (c 1.10, CHCl3); IR (neat) 3447, 3057, 2953, 2929, 2884, 2856, 2362, 2362, 1959, 1471, 1437, 1361, 1255, 1177, 1106, 1044, 1006, 936, 836, 807, 776, 709, 660 cm–1; 1H NMR (400 MHz, CDCl3) δ 0.13 (3H, s), 0.17 (3H, s), 0.92 (9H, s), 1.90 (1H, ddd, J = 13.2, 9.8, 3.7 Hz), 2.13 (1H, dd, J = 12.9, 5.6 Hz), 3.94–4.02 (2H, m), 4.13–4.21 (2H, m), 4.52 (1H, t, J = 2.9 Hz), 4.84–4.89 (1H, m), 5.43 (1H, t, J = 5.6 Hz), 6.09 (1H, t, J = 5.6 Hz); 13C NMR (CDCl3, 100 MHz) δ −4.8, −4.2, 18.0, 25.9, 41.5, 41.6, 50.6, 66.0, 73.2, 74.0, 75.7, 76.1, 85.4, 101.4, 201.4; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C15H26O379Br2NaSi 462.9910; Found 462.9914.

3.2.9. Sulfonate S1 (the Corresponding Diastereomer of 11)

To a solution of 9 (395 mg, 1.14 mmol) in THF (5.0 mL) was added 1.0 M NaOH solution (5.0 mL) at room temperature. The mixture was stirred for 1 h, extracted with Et2O, washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. Crude propargyl alcohol was directly employed in the next reaction.
To a solution of the crude propargyl alcohol in CH2Cl2 (5.0 mL) were added DMAP (366 mg, 3.00 mmol) and TrisCl (848 mg, 2.80 mmol) at room temperature under Ar atmosphere. The mixture was stirred for 12 h and concentrated in vacuo. The residue was purified by silica gel column chromatography (AcOEt:hexane = 2:98 then 8:92) to give sulfonate S1 (465 mg, 1.00 mmol, 88%) as a colorless oil: [α]D23 −18.5 (c 1.08, CHCl3); IR (neat) 3279, 2957, 2936, 2875, 2128, 1601, 1565, 1463, 1428, 1381, 1350, 1182, 1033, 895, 671 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.24 (3H, s), 1.25 (6H, d, J = 4.9 Hz), 1.27 (12H, d, J = 4.4 Hz), 1.48 (3H, s), 1.95 (1H, ddd, J = 14.4, 9.3, 4.9 Hz), 2.21 (1H, dd, J = 13.7, 4.9 Hz), 2.35 (1H, d, J = 2.0 Hz), 2.90 (1H, sep, J = 7.0 Hz), 4.13 (2H, sep, J = 6.7 Hz), 4.45 (1H, ddd, J =10.1, 4.9, 3.9 Hz), 4.71 (1H, t, J = 4.1 Hz), 5.32 (1H, dd, J = 3.4, 2.4 Hz), 5.73 (1H, t, J = 3.9 Hz), 7.16 (2H, s); 13C NMR (CDCl3, 100 MHz) δ 23.5, 24.5, 24.6, 24.7, 26.2, 26.9, 29.6, 33.7, 34.2, 69.5, 76.1, 78.7, 80.0, 106.0, 111.7, 123.6, 130.4, 150.7, 153.8; HRMS (ESI-orbitrap) m/z: [M + Na]+; Calcd for C23H36O6NaS 487.2125; Found 487.2121.

3.2.10. Bromoallene (1R)-12

To a solution of S1 (321 mg, 0.690 mmol) in THF (5.0 mL) were added LiBr (599 mg, 6.90 mmol) and CuBr (990 mg, 6.90 mmol) at room temperature under Ar atmosphere. The mixture was stirred at 60 °C for 2 h, quenched with saturated NaHCO3, filtered through celite pad, extracted with AcOEt, washed with brine, dried over Na2SO4, filtered through short silica gel pad, and concentrated in vacuo. The crude product was purified by silica gel column chromatography (AcOEt:hexane = 5:95) to give unsaturated bromoallene (1R)-12 (85.0 mg, 0.330 mmol, 47%) as a colorless oil: [α]D23 −101.7 (c 0.69, CHCl3); IR (neat) 3735, 2934, 1375, 1212, 1015, 850, 660 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.33 (3H, s), 1.53 (3H, s), 1.71 (1H, ddd, J = 13.4, 10.7, 4.4 Hz), 2.24 (1H, dd, J = 13.7, 4.4 Hz), 4.75–4.81 (2H, m), 5.50 (1H, t, J = 6.1 Hz), 5.85 (1H, d, J = 3.4 Hz), 6.08 (1H, dd, J = 5.6, 2.0 Hz); 13C NMR (CDCl3, 100 MHz) δ 26.1, 26.7, 39.1, 74.0, 74.5, 80.3, 99.5, 105.5, 111.3, 202.1; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C10H13O379BrNa 282.9940; Found 282.9940.

3.2.11. Unsaturated Ester (1R)-13

To a solution of (1R)-12 (349 mg, 1.34 mmol) in CH3CN-H2O (5.0 mL, 10/1) was added TsOH-H2O (35.0 mg) at room temperature under Ar atmosphere. The mixture was stirred at 60 °C for 6 h, quenched with saturated NaHCO3, extracted with AcOEt, washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. Crude hemiacetal was directly employed in the next reaction.
To a solution of the crude hemiacetal in CH2Cl2 (5.0 mL) was added nBu3P=CHCO2Et (1.00 M in toluene, 2.76 mL, 2.76 mmol) at room temperature under Ar atmosphere. The mixture was stirred for 1 h and concentrated in vacuo. The crude product was purified by silica gel column chromatography (AcOEt:hexane = 30:70) to give unsaturated ester (1R)-13 (154 mg, 0.530 mmol, 40% over 2 steps) as a colorless oil: [α]D23 −48.4 (c 0.50, CHCl3); IR (neat) 3851, 3735, 3649, 1698, 1540, 1181, 1034, 772 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.30 (3H, t, J = 7.1 Hz), 1.76–1.91 (2H, m), 4.20 (2H, q, J = 7.2 Hz), 4.60–4.64 (2H, m), 5.50 (1H, t, J = 5.6 Hz), 6.10 (1H, dd, J = 15.9, 2.0 Hz), 6.14 (1H, dd, J = 5.6, 2.0 Hz), 6.92 (1H, dd, J = 15.6, 4.9 Hz); 13C NMR (CDCl3, 100 MHz) δ 14.5, 43.3, 60.9, 69.1, 71.1, 75.3, 103.7, 121.0, 148.8, 166.7, 201.0; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C11H15O479BrNa 313.0046; Found 313.0046.

3.2.12. Bromoether (1R)-14

To a solution of (1R)-13 (134 mg, 0.460 mmol) in CH2Cl2 (3.0 mL) was added DIBAL (1.00 M in toluene, 2.30 mL, 2.30 mmol) at 0 °C under Ar atmosphere. The mixture was stirred for 30 min, quenched with 1.00 M HCl, stirred for 30 min, extracted with AcOEt, washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo to give crude alcohol, which was directly employed in the next reaction.
To a solution of the crude alcohol in CH3CN (5.0 mL) was added NBS (81.9 mg, 0.460 mmol) at 0 °C under Ar atmosphere. The mixture was stirred for 30 min, quenched with 20% Na2S2O3 aqueous solution, extracted with AcOEt, washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography (AcOEt:hexane = 20:80) to give bromoether (1R)-14 (76.0 mg, 0.230 mmol, 51% over 2 steps) as a colorless oil: [α]D23 −80.7 (c 0.52, CHCl3); IR (neat) 3900, 3851, 3735, 3647, 2931, 1698, 1540, 1457, 1038, 670 cm–1; 1H NMR (400 MHz, CDCl3) δ 2.04 (1H, ddd, J = 15.1, 6.1, 4.9 Hz), 2.25 (1H, dd, J = 13.4, 6.3 Hz), 3.98 (1H, dd, J = 12.1, 4.4 Hz), 4.04 (1H, dd, J = 12.2, 4.9 Hz), 4.15–4.24 (2H, m), 4.60 (1H, t, J = 3.9 Hz), 4.91–4.97 (1H, m), 5.44 (1H, t, J = 5.9 Hz), 6.08 (1H, dd, J = 5.6, 2.0 Hz); 13C NMR (CDCl3, 100 MHz) δ 30.9, 40.5, 51.1, 65.8, 74.2, 75.6, 84.1, 101.4, 201.4; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C9H12O379Br2Na 348.9045; Found 348.9048.

3.2.13. TBS Ether (1R)-15

To a solution of (1R)-14 (61.5 mg, 0.190 mmol) in CH2Cl2 (1.0 mL) were added 2,6-lutidine (110 μL, 0.950 mmol) and TBSOTf (131 μL, 0.570 mmol) at 0 °C under Ar atmosphere. The mixture was stirred at room temperature for 2 h, quenched with saturated NaHCO3, extracted with AcOEt, washed with 1.00 M HCl and brine, dried over Na2SO4, filtered, and concentrated in vacuo. Crude TBS ether (1R)-15 was sufficiently pure without column chromatography: [α]D23 −80.9 (c 0.23, CHCl3); IR (neat) 3903, 3733, 2926, 1714, 1507, 1258, 1118, 836, 670 cm–1; 1H NMR (400 MHz, CDCl3) δ 0.07 (3H, s), 0.08 (3H, s), 0.12 (3H, s), 0.16 (3H, s), 0.91 (18H, s), 1.91 (1H, ddd, J = 13.2, 10.2, 3.9 Hz), 2.10 (1H, dd, J = 13.2, 5.9 Hz), 3.97–4.10 (4H, m), 4.50 (1H, d, J = 3.4 Hz), 4.79–4.85 (1H, m), 5.45 (1H, t, J = 6.1 Hz), 6.04 (1H, dd, J = 5.9, 2.0 Hz); 13C NMR (CDCl3, 100 MHz) δ −5.6, −5.1, −4.7, 0.7, 17.7, 18.1, 25.5, 25.6, 29.4, 41.4, 52.2, 64.7, 64.8, 73.0, 73.4, 75.1, 76.9, 82.6, 82.6, 101.8, 201.1; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C21H40O379Br2NaSi2 577.0775; Found 577.0779.

3.2.14. Alcohol (1R)-8

To a solution of the crude (1R)-15 in CH2Cl2-MeOH (0.20 mL, 2:1) was added CSA (13.2 mg, 0.0570 mmol) at room temperature under Ar atmosphere. The mixture was stirred for 90 min, quenched with Et3N (7.90 μL, 0.0570 mmol), and concentrated in vacuo. The crude product was purified by silica gel column chromatography (AcOEt:hexane = 30:70) to give alcohol (1R)-8 (42.6 mg, 0.0969 mmol, 51% over 2 steps) as a colorless oil: [α]D23 −129.1 (c 0.30, CHCl3); IR (neat) 3447, 3057, 2954, 2929, 2884, 2856, 2362, 1959, 1474, 1437, 1361, 1255, 1178, 1108, 1044, 936, 836, 807, 776, 710 cm–1; 1H NMR (400 MHz, CDCl3) δ 0.13 (3H, s), 0.17 (3H, s), 0.92 (9H, s), 1.87 (1H, m), 2.11 (1H, dd, J = 13.1, 5.8 Hz), 2.62 (1H, dd, J = 8.0, 5.3 Hz), 3.95–4.01 (2H, m), 4.12 (1H, dd, J = 10.0, 2.4 Hz), 4.50–4.52 (1H, m), 4.83–4.89 (1H, m), 5.45 (1H, t, J = 5.8 Hz), 6.06 (1H, t, J = 5.6 Hz); 13C NMR (CDCl3, 100 MHz) δ −4.5, −4.0, 18.3, 26.1, 41.8, 50.8, 66.2, 73.6, 74.3, 76.0, 76.4, 85.7, 101.7, 201.8; HRMS (ESI-orbitrap) m/z: [M + Na]+; calculated for C15H26O379Br2NaSi 462.9910; Found 462.9914.

3.3. CD Calculations

Theoretical CD spectra were obtained by following a typical calculation procedure [34] as described in the following. The initial structure was constructed on a graphical user interface (GaussView) considering the absolute configuration of interest and subjected to a conformational search with CONFLEX 8 [39,40] using MMFF94S (2010-12-04HG) as the force field, in which the initial stable conformers were generated for up to 50 kcal/mol. Confirming that the absolute configuration in focus was retained, stable conformers with >1% of abundance were further optimized by the DFT method supposing acetonitrile as the solvent (polarizable continuum models: PCM) at the approximation level of double-zeta with the hybrid functional B3LYP and basis set 6-31G(d). The conformers obtained were analyzed their populations with their Boltzmann distribution. Based on their energies that were obtained from the internal energies and vibrational corrections, the stable conformers that covered >90% of abundance as summation were estimated (two conformers for (1S)-12, two for (1R)-12, five for (1S)-13, six for (1R)-13, one for (1S)-14, one for (1R)-14, one for (1S)-15, and one for (1R)-15). All the relevant conformers were subjected to time-dependent simulations (TD-DFT) at the level of double-zeta approximation using cc-pVDZ basis set and hybrid functional B3LYP in acetonitrile (PCM method). The resultant rotational strengths were converted into Gaussian curves (bandwidth sigma = 3000 cm–1) and summed to give the theoretical CD spectrum for each compound. The best match between the experimental and the theoretical ECD curves through all the compounds was obtained when B3LYP/cc-pVDZ was applied.

Supplementary Materials

The following are available online, Figure S1: Assignment of Absolute Configuration of Propargyl Alcohols 6 and 7.

Author Contributions

T.U. and T.N. designed the study; T.U. and N.M. synthesized the compounds; K.M. performed the VUVCD measurements; Y.T. and T.N. conducted the computational calculations; T.U. and T.N. acquired the funds; T.U., T.N., and F.M. analyzed the data and wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by JSPS Kakenhi grants (Nos. 15K16551, 16K14910, and 18H02271).

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are not available from the authors.

References

  1. Hoffmann-Röder, A.; Krause, Ν. Synthesis and Properties of Allenic Natural Products and Pharmaceuticals. Angew. Chem. Int. Ed. 2004, 43, 1196–1216. [Google Scholar] [CrossRef] [PubMed]
  2. Lowe, G. The Absolute Configuration of Allenes. Chem. Commun. 1965, 411–413. [Google Scholar] [CrossRef]
  3. Kinnel, R.; Duggan, A.J.; Eisner, T.; Meinwald, J. Panacene: An Aromatic Bromoallene from a Sea Hare (Aplysia brasiliana). Tetrahedron Lett. 1977, 18, 3913–3916. [Google Scholar] [CrossRef]
  4. Suzuki, M.; Koizumi, K.; Kikuchi, H.; Suzuki, T.; Kurosawa, E. Epilaurallene, a New Nonterpenoid C15-Bromoallene from the Red Alga Laurencia nipponica Yamada. Bull. Chem. Soc. Jpn. 1983, 56, 715–718. [Google Scholar] [CrossRef] [Green Version]
  5. Suzuki, T.; Koizumi, K.; Suzuki, M.; Kurosawa, E. Kumausallene, a New Bromoallene from the Marine Red Alga Laurencia nipponica Yamada. Chem. Lett. 1983, 12, 1639–1642. [Google Scholar] [CrossRef] [Green Version]
  6. Öztunç, A.; Imre, S.; Wagner, H.; Norte, M.; Fernández, J.J.; González, R. A New Haloether from Laurencia Possessing a Lauroxacyclododecane Ring. Structural and Conformational Studies. Tetrahedron 1991, 47, 2273–2276. [Google Scholar] [CrossRef]
  7. Suzuki, M.; Kondo, H.; Tanaka, I. The Absolute Stereochemistry of Okamurallene and Its Congeners, Halogenated C15 Nonterpenoids from the Red Alga Laurencia intricate. Chem. Lett. 1991, 20, 33–34. [Google Scholar] [CrossRef]
  8. Okamoto, Y.; Nitanda, N.; Ojika, M.; Sakagami, Y. Aplysiallene, a New Bromoallene as an Na, K-ATPase Inhibitor from the Sea Hare, Aplysia kurodai. Biosci. Biotechnol. Biochem. 2001, 65, 474–476. [Google Scholar] [CrossRef]
  9. Suzuki, M.; Takahashi, Y.; Mitome, Y.; Itoh, T.; Abe, T.; Masuda, M. Brominated Metabolites from an Okinawan Laurencia intricate. Phytochemistry 2002, 60, 861–867. [Google Scholar] [CrossRef]
  10. Gutiérrez-Cepeda, A.; Fernández, J.J.; Norte, M.; Souto, M.L. New Bicyclotridecane C15 Nonterpenoid Bromoallenes from Laurencia marilzae. Org. Lett. 2011, 13, 2690–2693. [Google Scholar] [CrossRef]
  11. Kokkotou, K.; Ioannou, E.; Nomikou, M.; Pitterl, F.; Vonaparti, A.; Siapi, E.; Zervou, M.; Roussis, V. An Integrated Approach Using UHPLC–PDA–HRMS and 2D HSQC NMR for the Metabolic Profiling of the Red Alga Laurencia: Dereplication and Tracing of Natural Products. Phytochemistry 2014, 108, 208–219. [Google Scholar] [CrossRef]
  12. Sutour, S.; Therrien, B.; von Reuss, S.H.; Tomi, F. Halogenated C15 Acetogenin Analogues of Obtusallene III from a Laurenciella sp. Collected in Corsica. J. Nat. Prod. 2018, 81, 279–285. [Google Scholar] [CrossRef]
  13. Umezawa, T.; Oguri, Y.; Matsuura, H.; Yamazaki, S.; Suzuki, M.; Yoshimura, E.; Furuta, T.; Nogata, Y.; Serisawa, Y.; Abe, T.; et al. Omaezallene from Red Alga Laurencia sp.: Structure Elucidation, Total Synthesis, and Antifouling Activity. Angew. Chem. Int. Ed. 2014, 53, 3909–3912. [Google Scholar] [CrossRef] [PubMed]
  14. Sohn, T.; Kim, D.; Paton, R.S. Substrate Controlled Asymmetric Total Syntheses of Microcladallenes A, B, and C Based on the Proposed Structures. Chem. Eur. J. 2015, 21, 15988–15997. [Google Scholar] [CrossRef] [PubMed]
  15. Ojima, N.; Sakai, K.; Fukazawa, T.; Gekko, K. Vacuum-Ultraviolet Circular Dichroism Spectrophotometer Using Synchrotron Radiation: Optical System and Off-line Performance. Chem. Lett. 2000, 29, 832–833. [Google Scholar] [CrossRef]
  16. Ojima, N.; Sakai, K.; Matsuo, K.; Matsui, T.; Fukazawa, T.; Namatame, H.; Taniguchi, M.; Gekko, K. Vacuum-Ultraviolet Circular Dichroism Spectrophotometer Using Synchrotron Radiation: Optical System and On-line Performance. Chem. Lett. 2001, 30, 522–523. [Google Scholar] [CrossRef]
  17. Dickerson, H.; Ferber, S.; Richardson, F.S. Molecular Orbital Calculations on the Optical Rotatory Properties of Chiral Allene Systems. Theor. Chim. Acta 1976, 42, 333–344. [Google Scholar] [CrossRef]
  18. Matsuo, K.; Gekko, K. Construction of a Synchrotron-Radiation Vacuum-Ultraviolet Circular-Dichroism Spectrophotometer and Its Application to the Structural Analysis of Biomolecules. Bull. Chem. Soc. Jpn. 2013, 86, 675–689. [Google Scholar] [CrossRef] [Green Version]
  19. Matsuo, K.; Gekko, K. Vacuum-Ultraviolet Circular Dichroism Study of Saccharides by Synchrotron Radiation Spectrophotometry. Carbohydr. Res. 2004, 339, 591–597. [Google Scholar] [CrossRef]
  20. Matsuo, K.; Matsushima, Y.; Fukuyama, T.; Senba, S.; Gekko, K. Vacuum-Ultraviolet Circular Dichroism of Amino Acids as Revealed by Synchrotron Radiation Spectrophotometer. Chem. Lett. 2002, 31, 826–827. [Google Scholar] [CrossRef]
  21. Matsuo, K.; Yonehara, R.; Gekko, K. Secondary-Structure Analysis of Proteins by Vacuum-Ultraviolet Circular Dichroism Spectroscopy. J. Biochem. 2004, 135, 405–411. [Google Scholar] [CrossRef] [PubMed]
  22. Matsuo, K.; Yonehara, R.; Gekko, K. Improved Estimation of the Secondary Structures of Proteins by Vacuum-Ultraviolet Circular Dichroism Spectroscopy. J. Biochem. 2005, 138, 79–88. [Google Scholar] [CrossRef]
  23. Egron, D.; Durand, T.; Roland, A.; Videl, J.-P.; Rossi, J.-C. C-Furanoside Synthesis via Intramolecular Cyclization. Synlett 1999, 435–437. [Google Scholar] [CrossRef]
  24. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. High-field FT NMR application of Mosher’s Method. The Absolute Configurations of Marine Terpenoids. J. Am. Chem. Soc. 1991, 113, 4092–4096. [Google Scholar] [CrossRef]
  25. Elsevier, C.L.; Vermeer, P.; Gedanken, A.; Runge, W. Synthesis and Absolute Configurations of Halogenoallenes. J. Org. Chem. 1985, 50, 364–367. [Google Scholar] [CrossRef]
  26. Grese, T.A.; Hutchinson, K.D.; Overman, L.E. General Approach to Halogenated Tetrahydrofuran Natural Products from Red Algae of the Genus Laurencia. Total Synthesis of (±)-Kumausallene and (±)-1-epi-Kumausallene. J. Org. Chem. 1993, 58, 2466–2477. [Google Scholar] [CrossRef]
  27. Harcken, C.; Martin, S.F. Improved E-Selectivity in the Wittig Reaction of Stabilized Ylides with α-Alkoxyaldehydes and Sugar Lactols. Org. Lett. 2001, 3, 3591–3593. [Google Scholar] [CrossRef]
  28. Saito, S.; Moriwake, Y.; Moriwake, T. Synthesis of Optically Pure 2,3,4,5-Substituted Tetrahydrofurans from a Bis-Allylic Framework via an Osmylation-Haloetherification Sequence. Synlett 1990, 523–524. [Google Scholar] [CrossRef]
  29. Saito, S.; Harunari, T.; Shimamura, N.; Asahara, M.; Moriwake, T. Protected Vicinal Diol Controller in Diastereoselective Reduction of β-Oxo Esters. Synlett 1992, 325–327. [Google Scholar] [CrossRef]
  30. Murata, Y.; Kamino, T.; Aoki, T.; Hosokawa, S.; Kobayashi, S. Highly Efficient Total Synthesis of (+)-Citreoviral. Angew. Chem. Int. Ed. 2004, 43, 3175–3177. [Google Scholar] [CrossRef]
  31. Houk, K.N.; Moses, S.R.; Wu, Y.D.; Rondan, N.G.; Jäger, V.; Schohe, R.; Fronczek, F.R. Stereoselective Nitrile Oxide Cycloadditions to Chiral Allyl Ethers and Alcohols. The “Inside Alkoxy” Effect. J. Am. Chem. Soc. 1984, 106, 3880–3882. [Google Scholar] [CrossRef]
  32. Bandur, N.G.; Brückner, D.; Hoffmann, R.W.; Koert, U. Total Synthesis of Jimenezin via an Intramolecular Allylboration. Org. Lett. 2006, 8, 3829–3831. [Google Scholar] [CrossRef]
  33. Elsevier, C.L.; Vermeer, P.; Gedanken, A.; Runge, W. Excited States of the Allene Chromophore: Photoelectron, Circular Dichroism, and Absorption Spectroscopy of Alkyl- and Halogenoallenes. J. Am. Chem. Soc. 1985, 107, 2537–2547. [Google Scholar] [CrossRef]
  34. Bringmann, G.; Bruhn, T.; Maksimenka, K.; Hemberger, Y. The Assignment of Absolute Stereostructures through Quantum Chemical Circular Dichroism Calculations. Eur. J. Org. Chem. 2009, 2717–2727. [Google Scholar] [CrossRef]
  35. Takekawa, H.; Tanaka, K.; Fukushi, E.; Matsuo, K.; Nehira, T.; Hashimoto, M. Roussoellols A and B, Tetracyclic Fusicoccanes from Roussoella hysterioides. J. Nat. Prod. 2013, 76, 1047–1051. [Google Scholar] [CrossRef] [PubMed]
  36. Kato, H.; Nehira, T.; Matsuo, K.; Kawabata, T.; Kobashigawa, Y.; Morioka, H.; Losung, F.; Mangindaan, R.E.P.; de Voogd, N.J.; Yokosawa, H.; et al. Isolation from the Marine Sponge Niphates olemda and Determination of its Absolute Configuration by an ECD Analysis. Tetrahedron 2015, 71, 6956–6960. [Google Scholar] [CrossRef]
  37. Goto, H.; Obata, N.; Nakayama, N.; Ohta, K. CONFLEX 8; CONFLEX Corporation: Tokyo, Japan, 2017. [Google Scholar]
  38. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; et al. Gaussian 09; Revision E.01; Gaussian, Inc.: Wallingford, CT, USA, 2009. [Google Scholar]
  39. Goto, H.; Osawa, E. Corner Flapping: A Simple and Fast Algorithm for Exhaustive Generation of Ring Conformations. J. Am. Chem. Soc. 1989, 111, 8950–8951. [Google Scholar] [CrossRef]
  40. Goto, H.; Osawa, E. An Efficient Algorithm for Searching Low-energy Conformers of Cyclic and Acyclic Molecules. J. Chem. Soc. Perkin Trans. 2 1993, 187–198. [Google Scholar] [CrossRef]
Molecules 26 01296 g001 550
Figure 1. Omaezallene (1) and derivatives.
Figure 1. Omaezallene (1) and derivatives.
Molecules 26 01296 g001
Molecules 26 01296 sch001 550
Scheme 1. Synthetic plan for both bromoallene diastereomers.
Scheme 1. Synthetic plan for both bromoallene diastereomers.
Molecules 26 01296 sch001
Molecules 26 01296 sch002 550
Scheme 2. Synthesis of bromoallenes.
Scheme 2. Synthesis of bromoallenes.
Molecules 26 01296 sch002
Molecules 26 01296 g002 550
Figure 2. Specific rotations (CHCl3) and VUVCD spectra (CH3CN) of bromoallenes.
Figure 2. Specific rotations (CHCl3) and VUVCD spectra (CH3CN) of bromoallenes.
Molecules 26 01296 g002
Molecules 26 01296 g003 550
Figure 3. Calculated CD spectra (CH3CN) of bromoallenes.
Figure 3. Calculated CD spectra (CH3CN) of bromoallenes.
Molecules 26 01296 g003
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Umezawa, T.; Mizutani, N.; Matsuo, K.; Tokunaga, Y.; Matsuda, F.; Nehira, T. Assignment of Absolute Configuration of Bromoallenes by Vacuum-Ultraviolet Circular Dichroism (VUVCD). Molecules 2021, 26, 1296. https://doi.org/10.3390/molecules26051296

AMA Style

Umezawa T, Mizutani N, Matsuo K, Tokunaga Y, Matsuda F, Nehira T. Assignment of Absolute Configuration of Bromoallenes by Vacuum-Ultraviolet Circular Dichroism (VUVCD). Molecules. 2021; 26(5):1296. https://doi.org/10.3390/molecules26051296

Chicago/Turabian Style

Umezawa, Taiki, Nakaba Mizutani, Koichi Matsuo, Yuugo Tokunaga, Fuyuhiko Matsuda, and Tatsuo Nehira. 2021. "Assignment of Absolute Configuration of Bromoallenes by Vacuum-Ultraviolet Circular Dichroism (VUVCD)" Molecules 26, no. 5: 1296. https://doi.org/10.3390/molecules26051296

APA Style

Umezawa, T., Mizutani, N., Matsuo, K., Tokunaga, Y., Matsuda, F., & Nehira, T. (2021). Assignment of Absolute Configuration of Bromoallenes by Vacuum-Ultraviolet Circular Dichroism (VUVCD). Molecules, 26(5), 1296. https://doi.org/10.3390/molecules26051296

Article Metrics

Back to TopTop